20 min listen
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
ratings:
Length:
20 minutes
Released:
Oct 4, 2023
Format:
Podcast episode
Description
This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!Content: - Definitions for "primary refractory" vs. "relapsed" disease- How do we approach patients with primary refractory disease? - What are the treatment regimens for patients with primary refractory disease?- What is the role of CAR-T therapy? - How do we "bridge" patients to CAR-T therapy? - How do we monitor patients post CAR-T? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Oct 4, 2023
Format:
Podcast episode
Titles in the series (100)
Episode 013: Heme/Onc Emergencies, Pt. 2: Brain Mets: Ronak Mistry, Vivek Patel, Dan Hausrath by The Fellow on Call: The Heme/Onc Podcast